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Point Detection of Pathogens in Oral Samples
Abstract
We have outlined our progress with respect to developing a novel device for monitoring oral samples for
bacterial and/or viral pathogens. The system is based on an existing device for measuring drugs of abuse in an
oral sample. The sample is collected on an absorbent pad that delivers a metered dose to the cassette. The
sample is then separated into 4 channels for the detection of antigen, RNA or DNA, and host antibodies to
the pathogen. The detection system involves the Upconverting Phosphor Technology (UPT), whereby the
captured pathogen analyte is detected by interrogation of the UPT particles with near-infrared light, and the
emitted visible light is detected by the analyzer. Several of the steps in this process have already been worked
out for viral and/or bacterial pathogens, and most of the remaining effort will be aimed at integrating these
steps into a single microfluidic device while maintaining the current sensitivity.
Keywords
Microfluidics, particle technology, up-converting phosphor technology (UPT), bioassays, point-of-care
diagnostics, lateral flow
Comments
Reprinted by permission. Reprinted in Advances in Dental Research, Volume 18, June 2005, pages 12-16.
Publisher URL: http://adr.iadrjournals.org/
This journal article is available at ScholarlyCommons: http://repository.upenn.edu/meam_papers/106
W
Introduction
e are developing a novel, oral-based system,
designed for use in the diagnosis of multiple
infectious diseases. Key to this project is a core
technology that permits the simultaneous analysis
of viral and/or bacterial antigens and nucleic acids, as well as
antibodies to these pathogens. While the project is focusing on
HIV, B. cereus, and V. cholerae for proof of principle, the
platform will be applicable for the detection of many other
infectious agents, including those associated with bioterrorism.
The detection of human pathogens with this system
involves first obtaining a biologic specimen (blood, urine,
saliva, oral mucosal transudate, nasal swab, etc.). Microfluidic
devices will be used to propel and channel the sample, which
then binds to a specific target zone for subsequent detection.
Current methods to detect analytes in biological samples
typically involve a reporter to identify the desired target
(Kricka, 1999; Whitcombe et al., 1998). The reporters may be
enzymes/substrates, chemiluminescence, fluorescence,
radiolabels, quantum dots, or visual determinations. Each of
these has potential problems associated with the background
signal that results in a decrease in the signal-to-noise ratio,
resulting in low analytical sensitivity. This, in turn, complicates
the investigator's ability to develop a multiplexed assay for
detection of several analytes in a single test.
Our platform is based on a phosphor particle technology
referred to as Up-converting Phosphor Technology (UPT).
These phosphors absorb 2 or more photons at a low frequency
and emit a signal at a higher frequency. Thus, UPT particles
absorb infrared light and emit visible photons. Since this up-
conversion relies on combinations of lanthanide-containing
crystals that do not exist in biological materials, sensitivity of
the UPT system is high, and the background is low (Zijlmans et
al., 1999; Hampl et al., 2001). Assays and devices based on UPT
have been developed to detect antigens and antibodies
(Niedbala et al., 2001), as well as nucleic acid sequences of
pathogens (Corstjens et al., 2001; Zuiderwijk et al., 2003). UPT
has also shown improved sensitivity in nucleic acid microarray
applications (van de Rijke et al., 2001).
The integrated system will collect and then introduce an
oral sample into a cassette and process it through 4 pathways
to detect pathogen-derived antigens, RNA, DNA, and host
antibodies to that pathogen. This will provide detailed
identification of viruses and/or bacteria and information on
the host immunological responses to those organisms. The
overall process design is diagrammed in Fig. 1. The detection
with phosphorescent UPT particles is carried out in the UPlink
reader (Fig. 2). The UPlink reader utilizes a low-power near-
infrared laser that interrogates the lateral flow strips. Note that
the UPT particles convert 2 or more photons of infrared light to
higher-energy visible light.
In this paper, we describe our progress in: (1) collector
studies, to identify the optimal collector for oral samples; (2)
evaluation of UPT sensitivity, as compared with a visual
immunogold technique; (3) microfluidic processing,
development of novel flow and PCR devices compatible with
the design pathway; and (4) multiplex detection formats.
Collector Studies
To develop a UPT-based system using oral samples to detect
multiple pathogens, we originally assessed 9 commercially
available oral collectors (Fig. 3A). Four of these collectors were
evaluated (see red box in Fig. 3A) in terms of their ability to
pick up and deliver fluid (saliva or buffer), protein (amylase),
and B. cereus (Holm-Hansen et al., 2004). In addition, we
demonstrated that samples of bacteria collected with all of the
collectors were compatible with subsequent DNA PCR, an
important consideration for the anticipated use of this
technology. Five collectors were excluded from the final study
based on esthetic qualities, low sample volume transferred, or
incompatibility with the system being developed. The
remaining four collectors were evaluated for ability to collect
and deliver fluid, protein, bacteria, and DNA. While each of
the collectors demonstrated specific advantages, we selected
the UPlink collector as most suitable for this project. The UPlink
collector is designed to deliver a metered fluid sample directly
into the lateral flow (LF) cassette (Fig. 3B). Within the cassette,
the fluid sample received on the sample application pad flows
past the UPT particles containing a biologic conjugate (antigen,
antibody, or short nucleic acid sequence), which then flows
past the target zones containing the specific capture reagent
(Fig. 3C).
Using the schematic shown in Fig. 1 as a guide, we have
begun to construct and evaluate each of the individual
pathways. After selection of the collector, studies focused on
incorporating PCR into the process, since this analysis is the
most complex aspect of the microfluidic platform (Kricka and
Wilding, 2003).
Evaluation of UPT Sensitivity
To determine the sensitivity of UPT-LF formats,  we
compared the detection of DNA PCR products with that in
an immunogold LF system (Roche Diagnostics B.V., Almere,
The Netherlands). Target DNA molecules were prepared by
PCR amplification of a specific nucleic acid fragment.
Primers with digoxigenin (Dig) or Biotin (Bio) hapten were
applied to provide each target DNA molecule with 2
different labels. In the LF assay, the Bio hapten on the target
DNA product was captured by avidin or streptavidin test
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lines on the lateral flow strips, whereas antibodies on the
UPT and gold reporter particles specifically bound the Dig
hapten label.
A dilution series of Dig-Bio tagged target DNA was
analyzed by lateral flow. We initiated the assay by adding
target DNA dilutions to the sample application pad, followed
by a buffer containing the UPT conjugate. The results were
compared with those achieved with commercial DNA
detection test strips (Roche Inc.) utilizing anti-Dig gold
conjugate for staining. With the latter test, a minimum of 1 ng
of DNA was detectable (Fig. 4, panel A). Since the sample
volume was 5 L for this specific assay, a PCR yield of 0.2
ng/L is required to get a positive signal; this is equivalent to
a minimum target DNA concentration of 600 fM. By
comparison, when the UPT detection system was applied (see
Fig. 4B), ~ 10 pg was detectable, thus reducing the minimum
target DNA to only 6 fM.
In the above-described format, sensitivity of detection
with UPT was improved by a factor > 100 compared with LF-
gold. Further improvement of sensitivity was observed when
Dig-Bio tagged target DNA was pre-incubated with the UPT-
conjugate prior to lateral flow. UPT-LF detection of ~ 106 non-
amplified nucleic acid targets from Streptococcus pneumoniae
has been demonstrated, utilizing hybridization with Dig and
Bio tagged probes (Zuiderwijk et al., 2003).
Microfluidic Processing
For nucleic acid analysis, we explored several PCR and RT-
PCR design types. The first system, referred to as Self-Actuated
Reactor (Chen et al., 2004), relies on the temperature variations
in PCR (94, 55, 72°C) to produce density variations in the fluid,
which in turn produces buoyancy forces and a continuous flow
circulation in a sealed system. This device was tested with B.
cereus genomic DNA and found to be as effective as the
traditional bench-top PCR unit in producing the correct size
amplicon (305 bp).
A second system utilizes a pneumatic oscillatory device to
move the reactants among the 3 heating zones (Fig. 5). This
system has also been used successfully on genomic B. cereus
DNA. The data shown in Fig. 5B present the results from a 60-
minute PCR reaction. By optimization of each step of the
reaction, we have been able to reduce this time to 28 min, and
have set a goal of 10-15 min for the nucleic acid amplification
steps. Note that the PCR product from the pneumatic PCR is
equivalent to that obtained with a standard bench-top PCR.
Furthermore, the amount of amplicon produced is influenced
by both cycle number and taq concentration.
Since the LF-UPT detection/UPlink system has a high
sensitivity, and since the analyzer and software already exist,
our plan is to modify the current cassette so that antigen,
antibodies, RNA, and DNA can be detected simultaneously.
Currently, it is possible to detect each of these analytes
individually, with nucleic acid amplification carried out with
the use of a bench-top PCR unit. We now plan to build an
integrated microfluidic system, including PCR amplification,
to accomplish a multiplexed detection format.
Fig. 1 — Schematic of overall sample-processing paths. An oral sample enters
the system and is divided into 4 aliquots. For antibody detection, the sample
binds to a specific antigen and is detected by UPT conjugated with antigen.
Soluble antigens can be detected directly, while bound antigen will require
extraction with heat or detergent, for example. In this path, antigen binds to a
specific capture antibody and is detected by UPT conjugated with antibody.
For DNA and RNA, it will be necessary to purify the sample partially and
amplify it by PCR or RT PCR prior to UPT detection.
Fig. 2 — The UPlink reader and IR up-conversion. (A) Existing UPlink analyzer.
(B) Schematic of Up-conversion process.
Fig. 3 — Commercially available collectors evaluated. (A) Collectors shown
were obtained from the following sources: CytoBrush (Cooper Companies,
Inc., Medscand Medical AB, Malmö, Sweden), BBL white cap (Becton
Dickinson and Co., Sparks, MD, USA), UPlink collector (OraSure Technologies
Inc., Bethlehem, PA, USA), OraSure HIV-1 Oral Fluid Specimen Device (OraSure
Technologies, Bethlehem, PA, USA), TRANSORB wicks (Filtrona Richmond Inc,
Colonial Heights, VA, USA), Toothette-Plus Swabs (Sage Products Inc., Crystal
Lake, IL, USA), BBL Culture Swab, orange cap (Becton Dickinson and Co.), and
BBL red cap [EZ] (Becton Dickinson and Co.). The red-dashed box around four
of the collectors indicates those chosen for detailed comparison. (B) The
Orasure UPlink collector and analysis cassette and (C) an annotated schematic
of the lateral flow nitrocellulose strip in the UPlink cassette.
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Multiplex Detection Formats
Multiple target capture zones: Trans-Dot strips
Improved detection sensitivity in rapid lateral flow systems,
through incorporation of UPT, facilitates increased assay
robustness, and capture of multiple targets utilizing a linear
array of various trapping molecules appears feasible.
Multiple target-capture molecules can be aligned
perpendicular or parallel to the flow (Fig. 6). Perpendicular
placement of capture zones is preferred, since it eliminates
differences in signal intensity, since the distance from the
sample pad to all capture zones is constant. Moreover,
perpendicular placement eliminates the requirement of the
sample to pass through alternate capture zones. Potential
interference of preceding target capture zones can thus be
ignored in assay development.
Lateral flow strips with perpendicularly placed capture
zones (Trans-Dot strips) were developed to fit in the UPlink
cassette so that scanning was possible in the existing UPlink
reader. A prototype of the TD-cassette is shown in Fig. 7.
Modifications were accomplished such that the existing
scanning/read window remained in place.
Nanoliter capture spots were prepared with the use of a
BioDot apparatus (BioDot Inc., Irvine, CA, USA). For initial
experiments, 4-cm-wide strips were used with 2-mm anti-Bio
antibody dots separated by 1-mm BSA dots. The BSA dots were
added to help create a continuous flow pattern by generating an
uninterrupted protein barrier. A serial dilution of Dig-Bio DNA
(a 500-bp PCR fragment from Vibrio cholerae) was analyzed
following pre-incubation of the DNA with the UPT-conjugate.
The lowest amount of DNA tested (1 ng) was detected with a
background-to-signal ratio of approximately 10 (Fig. 8), signals
obtained with 10 ng of DNA or higher saturated and clipped at
60,000 RFU. This configuration can accommodate up to 400 L
of sample in a total assay volume of 500 L, so this particular
assay yields a sensitivity of 6 pM. Note that the signal response
in all 8 capture dots is highly reproducible. In comparison with
conventional lateral flow strips, TD strips allow a larger sample
volume to be used. The expected detection sensitivity with TD is
in the high-fM range. Sensitive detection of multiple antigens,
antibodies, or abundant (non-amplified) nucleic acids in a single
sample is feasible with this system.
The consecutive-flow format
UPT labels are valuable for the simultaneous detection of
multiple analytes in a single sample. Initial coupling, with a
Universal Linkage System (ULS®; KREATECH Biotechnology
B.V., Amsterdam, The Netherlands), of the entire population of
macromolecules present in a sample allows for the use of
generic UPT labels. However, this requires a capture system
that enriches for the analytes of interest prior to binding of the
generic UPT reporter. To provide such enrichment in a lateral
flow system, the ULS tagged sample was 'flowed over' the
lateral flow LF strip prior to the UPT reporter flow. The ULS-
tagged targets of interest bind to their specific capture zones on
the LF strip, and the unbound analytes are removed by
washing. Finally, a subsequent flow with the generic UPT
Fig. 4 — Comparison of immunogold detection with UPT detection. (A) The
results obtained with LF-gold (strips containing an integrated gold conjugate
pad). The upper line is the test line (streptavidin), and the lower line is the
flow control line. (B) The results obtained with LF-UPT. The lateral flow strips
used for LF-UPT contained an avidin test line and an anti-mouse antibody
control line, as described earlier (Corstjens et al., 2001) on high-flow
nitrocellulose (SRHF04000; Millipore Inc.). LF-UPT analysis was performed with
100 ng of anti-Dig UPT conjugate. UPT signals represent visible emission after
IR excitation of the test line; signals are normalized to the signal obtained with
100 ng Dig-Bio tagged DNA.
Fig. 5 — Pneumatic microfluidic
oscillatory PCR reactor. (A) A schematic
of the PCR device. (B) Ethidium-
bromide-stained agarose gel of PCR
products [Lane 1, control (benchtop
thermocycler); lane 2, pneumatic, 35
cycles; lane 3, pneumatic, 25 cycles;
lane 4, pneumatic, 25 cycles, 2X taq].
Arrow indicates the size of the
anticipated PCR product of 305 bp.
Fig. 6 — Multiple capture lines on conventional lateral flow strips and Trans-
Dot (TD) strips. (A) Diagram of a conventional, parallel lateral flow format. (B)
Schematic of a Trans-Dot (TD) lateral flow strip.
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reporter label is performed, allowing the reporter to bind to the
Dig tag at locations on the strip where specific binding of the
ULS-tagged target has occurred. This flow format is referred to
as the 'consecutive-flow' format.
The feasibility of the above-described consecutive flow
was tested with a 500-bp Vibrio cholerae DNA fragment
provided with multiple Dig hapten by PCR by incorporation of
digoxigenin-11-dUTP nucleotides (Fig. 9A). Subsequent ULS
labeling was used to provide part of the Dig-tagged DNA with
either fluorescein (Flu) or biotin (Bio). Various combinations of
Dig, Dig-Bio, and Dig-Flu DNA were combined and tested
with consecutive flow and an UPTMDig-conjugate. The capture
of the various hapten (Dig, Flu, and Bio)-tagged DNA
fragments did not show any cross-interference (Fig. 9B). In the
assay, the amount of Dig hapten was kept constant, while the
amounts of Bio and Flu hapten were varied. Signals detected
were directly related to the total amount of a specific hapten
present in the sample. The signal was not influenced by the
number of different haptens present in the sample. This
experiment demonstrates the feasibility of the combination of
TD strips, consecutive flow, and ULS and a generic UPT label.
The detection of multiple antibodies and antigens can be
envisaged with this system.
Compared with gold, the application of UPT in lateral
flow formats leads to 100-fold-improved sensitivity. It has been
demonstrated that, in fully optimized UPT-LF systems, the
current limit of detection is ~ 106 target molecules. (With a 100-
L sample volume, this would be the equivalent of a sample
with a target concentration in the range of 1 fM.) This
enhancement in sensitivity allows for expansion of the assay's
complexity, i.e., testing for the presence of more than one target
in a single sample. In this respect, the consecutive-flow format,
combined with trans-dot strips, may be ideal for multiplex
assays. Moreover, the combination of TD with target labeling
and consecutive flow allows for the convenient usage of a
generic UPT label.
Summary
We have outlined our progress with respect to developing a
Fig. 7 — Cassette modified for transverse UPlink UPT scanning. Note that a
new window, the sample application window, has been added, and the
'cassette read' window remains intact.
Fig. 8 — Analysis with BioDot Trans-Dot strips. The top panel represents the blank
(no DNA), the middle panel shows the signal obtained with 1 ng DNA, and the
bottom panel that with 10 ng DNA. Note that the highest sensitive scale was
plotted for all 3 panels, to allow sensitivity to be compared with the blank.
Fig. 9 — Universal labeling and consecutive flow with a generic UPT reporter.
(A) Diagram of Universal Labeling System (ULS). (B) The total amount of a
500-bp DNA fragment from Vibrio cholerae in each sample was kept constant
at 3 ng, so that each sample contained the same amount of digoxigenin
hapten. The 50% Flu sample contained 1.5 ng of Flu-Dig and 1.5 ng of Dig-
tagged DNA, and the 0% Flu sample contained 3 ng of Dig-tagged DNA only.
DNA mixtures were added to 200 L of running buffer and flowed over a 2.5-
cm-wide TD strip spotted with 25 ng of anti-Bio, anti-CAA, anti-Dig, and anti-
Flu antibody. As soon as the sample was adsorbed by the sample pad, an
additional 100 L of buffer was applied. Finally, 200 L of buffer containing 1
g of UPT particles was applied to the TD strips, and strips were allowed to
air-dry for 5 min before IR scanning occurred.
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novel device for monitoring oral samples for bacterial and/or
viral pathogens. The system is based on an existing device for
measuring drugs of abuse in an oral sample. The sample is
collected on an absorbent pad that delivers a metered dose to
the cassette. The sample is then separated into 4 channels for
the detection of antigen, RNA or DNA, and host antibodies to
the pathogen. The detection system involves the Up-
converting Phosphor Technology (UPT), whereby the captured
pathogen analyte is detected by interrogation of the UPT
particles with near-infrared light, and the emitted visible light
is detected by the analyzer. Several of the steps in this process
have already been worked out for viral and/or bacterial
pathogens, and most of the remaining effort will be aimed at
integrating these steps into a single microfluidic device while
maintaining the current sensitivity.
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